TP53 and cancer: In this scenario, p53-effector microRNAs may contribute to cell cycle arrest, inhibition of epithelial-to-mesenchymal transition (EMT), hormone-specific response and induction of apoptosis, enforcing p53-mediated tumor suppressor activity in cancer cells.